Growth hormone deficiency impedes the rise in plasma insulin-like growth factor I levels associated with precocious puberty
- PMID: 2738797
- DOI: 10.1016/s0022-3476(89)80330-0
Growth hormone deficiency impedes the rise in plasma insulin-like growth factor I levels associated with precocious puberty
Abstract
We tested the hypothesis that growth hormone (GH) mediates the rise in insulin-like growth factor I (IGF-I) concentrations in children with precocious puberty. We studied three groups of patients. Group 1 included six children with GH deficiency and precocious puberty (precocious GH-deficient); group 2 included 10 GH-sufficient patients with idiopathic true precocious puberty (precocious GH-sufficient); and group 3 included 9 prepubertal children with GH deficiency (prepubertal GH-deficient). Growth rates, pubertal status, and plasma IGF-I concentrations were determined at regular intervals. The precocious children with GH deficiency had a mean (+/- SD) growth rate of 7.2 +/- 2.1 significantly below that of the precocious GH-sufficient patients (10.5 +/- 2.5 cm/yr, p less than 0.05) but above that of the prepubertal GH-deficient children (3.9 +/- 1.4 cm/yr, p less than 0.05). The mean IGF-I concentration in the precocious GH-deficient children was 0.77 +/- 0.39 U/ml, significantly lower than the mean level of 2.2 +/- 0.67 U/ml in the precocious GH-sufficient patients (p less than 0.01). However, precocious GH-deficient patients had significantly higher IGF-I values than the prepubertal GH-deficient children (0.24 +/- 0.10 U/ml, p less than 0.05). IGF-I values did not rise with the onset of precocious puberty in four of the precocious GH-deficient children evaluated before and after the development of precocious puberty. However, three patients who began GH treatment did have a rise in plasma IGF-I concentrations to levels of 1.2, 3.4, and 3.7 U/ml, respectively. These findings are compatible with the concept that sex steroids increase IGF-I levels in precocious puberty primarily by increasing GH production. A small but direct effect of sex steroids on IGF-I production may also exist. The onset of precocious puberty in children with organic GH deficiency may mask the abnormal growth pattern of these children and delay diagnosis; determinations of plasma IGF-I concentrations may be helpful in assessing the GH status of these patients.
Similar articles
-
The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids.J Clin Endocrinol Metab. 1990 Oct;71(4):975-83. doi: 10.1210/jcem-71-4-975. J Clin Endocrinol Metab. 1990. PMID: 2401720
-
Somatomedin-C and growth in children with precocious puberty: a study of the effect of the level of growth hormone secretion.J Clin Endocrinol Metab. 1987 Dec;65(6):1112-7. doi: 10.1210/jcem-65-6-1112. J Clin Endocrinol Metab. 1987. PMID: 3680478
-
Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.J Pediatr. 1992 May;120(5):709-15. doi: 10.1016/s0022-3476(05)80232-x. J Pediatr. 1992. PMID: 1533661
-
[Relation of the secretion of growth hormone (GH), somatomedin C/IGF I (IGF I) and steroids before and after the beginning of puberty in patients of short stature].Pathol Biol (Paris). 1990 Feb;38(2):105-12. Pathol Biol (Paris). 1990. PMID: 2138277 Review. French.
-
The measurement of insulin-like growth factor I: clinical applications and significance.Ann Clin Biochem. 1986 Jul;23 ( Pt 4):413-24. doi: 10.1177/000456328602300406. Ann Clin Biochem. 1986. PMID: 3094423 Review.
Cited by
-
Comparing adult height gain and menarcheal age between girls with central precocious puberty treated with gonadotropin-releasing hormone agonist alone and those treated with combined growth hormone therapy.Ann Pediatr Endocrinol Metab. 2019 Jun;24(2):116-123. doi: 10.6065/apem.2019.24.2.116. Epub 2019 Jun 30. Ann Pediatr Endocrinol Metab. 2019. PMID: 31261476 Free PMC article.
-
Relationship between serum insulin-like growth factor-1, IGF binding protein-3 levels and body height before and after gonadotropin-releasing hormone agonist therapy.Ann Pediatr Endocrinol Metab. 2014 Dec;19(4):208-13. doi: 10.6065/apem.2014.19.4.208. Epub 2014 Dec 31. Ann Pediatr Endocrinol Metab. 2014. PMID: 25654067 Free PMC article.
-
The Efficacy of GnRHa Alone or in Combination with rhGH for the Treatment of Chinese Children with Central Precocious Puberty.Sci Rep. 2016 Apr 13;6:24259. doi: 10.1038/srep24259. Sci Rep. 2016. PMID: 27072597 Free PMC article.
-
Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty.Sci Rep. 2023 Jan 23;13(1):1264. doi: 10.1038/s41598-023-28602-3. Sci Rep. 2023. PMID: 36690835 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources